Late-Breaking Abstracts will be considered for presentation and publication at the 21st International Congress in Vancouver, BC, Canada if they fulfill the following criteria:
1) The topic must be of critical importance to the clinical/scientific community and/or the public.
2) The abstract must report data that became available for public dissemination only after the deadline of the regular abstract submission (January 6, 2017), and has not previously published or presented.
3) The study and results reported should be novel (not simply an extension of previously published work) or be definitive if confirming or refuting other critically important work.
4) The following categories are typically suited to the main poster sessions and will not be considered for Late-Breaking Abstracts: case reports, qualitative surveys, reviews of existing treatments, practice reviews, rating scale validation, small confirmatory studies, small scale epidemiology studies, research proposals.
5) The Late-Breaking Abstract program is not designed to favor investigators who inadvertently missed the deadline for regular abstract submission.
Late-Breaking Abstract Submission Instructions
- The deadline to submit a Late-Breaking Abstract is April 3, 2017 (11:59 pm CST). Deadline extension requests will not be granted. Acceptance notifications will be sent via e-mail to the submitting author in mid-April 2017.
- MDS Members and non-members are eligible to submit abstracts.
- All eligible submissions must meet the criteria noted in this form.
- All abstract submissions must be written and presented in English. Please be mindful to write out acronyms and avoid using special characters and/or symbols when submitting your abstract.
- There is no fee to submit an abstract. All abstract presenters are required to register for the International Congress and pay applicable registration fees.
- Please submit your abstract only if you are ready to travel and attend the International Congress in Vancouver, BC, Canada June 4-8, 2017 to present your work.
- Eligible submissions cannot have been previously published or presented at another meeting or forum.
MDS only accepts original work. By submitting your abstract, you affirm that your abstract is your own, either individually or of a group. Should plagiarism be detected, the abstract will be rejected.
For any questions or concerns, please contact the MDS International Secretariat at email@example.com.